ACUPAN

This brand name is authorized in France, New Zealand, Romania, Tunisia, United Kingdom

Active ingredients

The drug ACUPAN contains one active pharmaceutical ingredient (API):

1 Nefopam
UNII 685J48E13W - NEFOPAM HYDROCHLORIDE
Read about Nefopam

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ACUPAN Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02BG06 Nefopam N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics
Discover more medicines within N02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 62580656
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2482
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43861001, W43861002
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 5193031

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.